Earnings calendar/KPTI
Karyopharm Therapeutics Inc. (KPTI)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 2, 2026
Consensus estimate row
EPS target
$-1.16
Street estimate
Revenue target
$33.5M
Street estimate
Trailing EPS (avg 4Q)
$-3.26
Beat rate last 4: 25%
Latest EPS YoY
+46.3%
vs 2025-08-11
Latest revenue YoY
-11.9%
How results look so far
Trailing revenue (avg 4Q)
$36.7M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 13, 2026
EPS miss
EPS actual / est
$-2.32 / $-1.37
-69.3%
Revenue actual / est
$33.4M / $32.2M
+3.8%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/2/2026upcoming | $-1.16 | Pending | — | $33.5M | Pending | — |
| 8/13/2026 | $-1.37 | $-2.32 | -69.3% | $32.2M | $33.4M | +3.8% |
| 8/10/2026upcoming | $-1.37 | Pending | — | $32.2M | Pending | — |
| 5/14/2026 | $-1.45 | $-1.24 | +14.5% | $31.4M | $35.1M | +11.7% |
| 5/11/2026upcoming | $-1.45 | Pending | — | $31.4M | Pending | — |
| 2/18/2026upcoming | $-2.26 | Pending | — | — | Pending | — |
| 2/12/2026 | $-2.26 | $-5.68 | -151.3% | $35.1M | $34.1M | -2.9% |
| 11/3/2025 | $-3.47 | $-3.82 | -10.1% | $42.1M | $44.0M | +4.7% |
| 8/11/2025 | $-3.80 | $-4.32 | -13.7% | $38.0M | $37.9M | -0.3% |
| 5/12/2025 | $-4.21 | $-2.77 | +34.2% | $35.1M | $30.0M | -14.5% |
| 2/19/2025 | $-0.25 | $-3.60 | -1340.0% | $35.7M | $30.5M | -14.4% |
| 11/5/2024 | $-3.94 | $-3.90 | +1.1% | $37.9M | $38.8M | +2.3% |
| 8/6/2024 | $-4.35 | $-3.00 | +31.0% | $36.2M | $42.8M | +18.2% |
| 5/8/2024 | $-4.95 | $-4.80 | +3.0% | $34.5M | $33.1M | -3.9% |
| 2/29/2024 | $-0.31 | $-5.40 | -1641.9% | $35.4M | $33.7M | -4.7% |
| 11/2/2023 | $-4.20 | $-4.50 | -7.1% | $37.3M | $36.0M | -3.4% |
| 8/2/2023 | $-5.10 | $-4.35 | +14.7% | $35.7M | $37.6M | +5.3% |
| 5/4/2023 | $-0.37 | $-4.50 | -1116.2% | $36.3M | $38.7M | +6.6% |
| 2/15/2023 | $-0.35 | $-0.43 | -21.8% | $34.4M | $33.6M | -2.5% |
| 11/3/2022 | $-8.40 | $-0.45 | +94.6% | $34.8M | $36.1M | +3.8% |
| 8/4/2022 | $-9.45 | $-0.62 | +93.4% | $36.0M | $39.7M | +10.3% |
| 5/5/2022 | $-9.45 | $-0.53 | +94.4% | $34.4M | $47.7M | +38.5% |
| 2/8/2022 | $-6.00 | $0.46 | +107.7% | $52.7M | $126.3M | +139.5% |
| 11/3/2021 | $-10.19 | $-10.34 | -1.5% | $25.8M | $37.7M | +46.1% |
| 8/5/2021 | $-10.79 | $-10.64 | +1.4% | $22.6M | $22.6M | 0.0% |
| 5/3/2021 | $-10.49 | $-11.54 | -10.0% | $26.6M | $23.3M | -12.5% |
| 2/11/2021 | $-8.70 | $-8.85 | -1.7% | $27.4M | $35.1M | +28.2% |
| 11/2/2020 | $-10.94 | $-10.94 | 0.0% | $21.0M | $21.3M | +1.4% |
| 8/4/2020 | $-8.55 | $-9.45 | -10.5% | $30.9M | $33.5M | +8.6% |
| 5/5/2020 | $-10.49 | $-11.69 | -11.4% | $16.0M | $18.1M | +13.0% |
| 2/13/2020 | $-9.90 | $-11.39 | -15.1% | $16.0M | $18.1M | +13.4% |
| 11/4/2019 | $-12.59 | $-10.04 | +20.3% | $16.3M | $13.1M | -19.3% |
| 8/6/2019 | $-14.54 | $-10.64 | +26.8% | $13.1M | $9.5M | -27.6% |
| 5/9/2019 | $-12.59 | $-16.34 | -29.8% | $123,715.6 | $155,000 | +25.3% |
| 2/28/2019 | $-13.19 | $-14.39 | -9.1% | $182,395.83 | $206,000 | +12.9% |
| 11/8/2018 | $-13.19 | $-11.84 | +10.2% | $269,253.16 | $239,000 | -11.2% |
| 8/7/2018 | $-11.39 | $-9.00 | +21.0% | $26.9M | $19.9M | -25.9% |
| 5/10/2018 | $-10.04 | $-11.69 | -16.4% | $7.9M | $10.0M | +25.8% |
| 3/15/2018 | $-9.90 | $-11.99 | -21.1% | $1.2M | $1.5M | +23.1% |
| 11/2/2017 | $-9.30 | $-9.75 | -4.8% | $69,907.69 | Pending | — |
| 8/8/2017 | $-9.60 | $-9.60 | 0.0% | $3,046.88 | $3,000 | -1.5% |
| 5/4/2017 | $-10.04 | $-10.64 | -6.0% | $64,169.01 | $68,000 | +6.0% |
| 3/16/2017 | $-9.75 | $-9.75 | 0.0% | $47,723.08 | $47,000 | -1.5% |
| 11/7/2016 | $-11.99 | $-10.34 | +13.8% | $56,347.83 | $48,000 | -14.8% |
| 8/4/2016 | $-11.39 | $-9.90 | +13.1% | $53,380.95 | $59,000 | +10.5% |
| 5/9/2016 | $-10.79 | $-9.15 | +15.2% | — | Pending | — |
| 3/14/2016 | $-12.59 | $-9.90 | +21.4% | $25,308.64 | $25,000 | -1.2% |
| 11/9/2015 | $-13.49 | $-12.74 | +5.6% | $76,764.71 | $75,000 | -2.3% |
| 8/10/2015 | $-11.69 | $-11.84 | -1.3% | $125,543.48 | $150,000 | +19.5% |
| 5/11/2015 | $-11.24 | $-9.60 | +14.6% | — | Pending | — |
| 3/16/2015 | $-9.90 | $-11.84 | -19.6% | $12,341.77 | $16,000 | +29.6% |
| 11/10/2014 | $-7.95 | $-9.15 | -15.1% | $17,901.64 | $21,000 | +17.3% |
| 8/7/2014 | $-7.65 | $-8.25 | -7.8% | $19,600 | $21,000 | +7.1% |
| 5/7/2014 | $-6.75 | $-6.90 | -2.2% | $174,717.39 | $171,000 | -2.1% |
| 3/21/2014 | — | $-0.41 | — | — | $21,000 | — |
| 3/5/2014 | $-0.34 | $-2.00 | -488.2% | $65,790 | $21,000 | -68.1% |
| 6/30/2013 | — | $-2.86 | — | — | $133,000 | — |
| 3/31/2013 | — | $-2.52 | — | — | $233,000 | — |
| 12/31/2012 | — | $-0.43 | — | — | $33,000 | — |
| 9/30/2012 | — | $-1.97 | — | — | $34,000 | — |
Need KPTI data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.